iifl-logo

Nectar Lifescience Ltd Quarterly Results

14.11
(-4.66%)
Nov 24, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Sept-2025Jun-2025Mar-2025Dec-2024Sept-2024

Gross Sales

5.87

6.15

489.32

504.12

6.71

Excise Duty

0.87

0.92

60.41

49.79

0.99

Net Sales

5

5.23

428.91

454.33

5.73

Other Operating Income

0.71

0.01

1.79

0.65

0.01

Other Income

0.03

0.32

0.08

0.57

6.52

Total Income

5.74

5.56

430.77

455.56

12.25

Total Expenditure

181.72

68.63

585

410.27

6.32

PBIDT

-175.98

-63.07

-154.23

45.28

5.93

Interest

0

0

17.67

17.12

0

PBDT

-175.98

-63.07

-171.9

28.16

5.93

Depreciation

0.2

0.53

15.77

15.61

0.45

Minority Interest Before NP

0

0

0

0

0

Tax

0

0

0

0

0

Deferred Tax

-0.18

-0.37

-57.58

4.71

-0.12

Reported Profit After Tax

-176.01

-63.23

-130.09

7.84

5.6

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-176.01

-63.23

-130.09

7.84

5.6

Extra-ordinary Items

-175.68

-62.55

0

0

5.83

Adjusted Profit After Extra-ordinary item

-0.32

-0.68

-130.09

7.84

-0.23

EPS (Unit Curr.)

-7.84

-2.82

-5.8

0.35

0.25

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

22.43

22.43

22.43

22.43

22.43

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-3,519.6

-1,205.92

-35.95

9.96

103.49

PBDTM(%)

-3,519.6

-1,205.92

-40.07

6.19

103.49

PATM(%)

-3,520.2

-1,208.98

-30.33

1.72

97.73

Nectar Lifesci.: Related NEWS

European Regulators Raise Concerns Over Nectar Lifesciences’ API Facility

The facility was inspected primarily to assess its compliance with European Good Manufacturing Practices (EuGMP).

11 Mar 2025|01:42 PM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.